Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial-Reference-Cited by-同舟云学术

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial

Published:2021-09 Issue:9 Volume:16 Page:1512-1522
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lu Shun^ORCID,Wang Jie,Yu Yan,Yu Xinmin,Hu Yanping,Ai Xinghao,Ma Zhiyong,Li Xingya,Zhuang Wu,Liu Yunpeng,Li Weidong,Cui Jiuwei,Wang Dong,Liao Wangjun,Zhou Jianying,Wang Zhehai,Sun Yuping,Qiu Xiusong,Gao Jie,Bao Yuanyuan,Liang Liang,Wang Mengzhao

Funder

BeiGene

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. The Global Cancer Observatory, WHO. Lung SOURCE: Globocan 2020. https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf. Accessed January 21, 2021.

2. Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer;Wu;Lung Cancer,2014

3. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018

4. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial;West;Lancet Oncol,2019

5. National Comprehensive Cancer Network. Non-small cell lung cancer. version 6.2020). https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed June 15, 2020.

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer;Cancer Cell;2024-09

2. Tislelizumab synergizes with surgery to augment the survival benefit in stage II-III non-small cell lung cancer;Discover Oncology;2024-08-31

3. Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer;Cochrane Database of Systematic Reviews;2024-08-13

4. Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy with Cryoablation in the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC): a pilot study protocol for a single center, single arm, phase II study (Preprint);2024-07-31

5. A real-world analysis of stereotactic body radiotherapy combined with immunotherapy in advanced or recurrent non-small cell lung cancer (NSCLC): A single-center experience;Clinical and Translational Radiation Oncology;2024-07